Tyrosine Kinases as Druggable Targets in Cancer
Protein tyrosine kinase (PTK) deregulation contributes to growth of cancer and many other diseases. The development of small-molecule tyrosine kinase inhibitors (TKIs) that target the deregulated PTKs, such as epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) and Bcr-ABL...
Сохранить в:
| Формат: | Online |
|---|---|
| Язык: | английский |
| Опубликовано: |
IntechOpen
2021
|
| Предметы: | |
| Online-ссылка: | ONIX_20210420_9781789848090_2372 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|